Skip to main content

Suction-Assisted Protein Lipectomy (SAPL / Liposuction)

Lymphedema liposuction removes excess subcutaneous adipose and fibrotic tissue in selected patients whose swelling remains predominantly non-pitting despite appropriate conservative treatment. It is a reductive operation: it does not reliably restore normal lymphatic drainage, and established standalone protocols require ongoing, generally lifelong, compression to maintain the result. The supporting evidence concerns mainly arm and leg lymphedema; it should not be transferred directly to penile or scrotal surgery.[1][2][3]

For conservative care see CDT. For genital disease see Genital Lymphedema, Debulking Scrotoplasty and Modified Charles Procedure. Physiologic options are discussed in LVA, VLNT and LYST.

What the Operation Treats​

Chronic lymphatic failure can produce both fluid accumulation and enlargement of adipose/fibrotic tissue. These components overlap. Pitting, tissue consistency, skin changes and imaging when useful guide treatment; the ISL limb stage alone does not identify the amount of removable fat or dictate a genital operation.[1][3]

Dominant findingPractical implication
Substantial mobile fluid/pittingOptimize conservative edema control and assess lymphatic function before deciding on tissue reduction
Persistent excess adipose tissue with little pittingSpecialized liposuction may reduce bulk when conservative care has reached a plateau
Diseased skin, ulceration, large redundant folds or dense genital elephantiasisLiposuction alone cannot replace removal and reconstruction of a diseased skin envelope
Mixed disease or previous lymphatic reconstructionConsider an individualized combined or staged plan that protects useful collectors, bypasses and transferred tissue

These are selection principles, not a validated sequence requiring LVA or VLNT before every liposuction procedure.[1][2][3][8]

SAPL, suction-assisted lipectomy and lymphedema liposuction describe the therapeutic aim. Power assistance describes the cannula device; dry, wet and tumescent techniques describe infiltration. They are not interchangeable names for a single mandatory operative method.[4][7][9]

Selection and Preparation​

Assessment should include the cause of swelling, cancer status where relevant, previous lymphatic operations, skin health, recurrent infection, functional burden and the patient's goals. Treat active infection before elective tissue reduction. Establish access to an experienced lymphedema therapist and a feasible compression plan before surgery.[1][3][7]

  • Document a plateau after appropriate conservative treatment, rather than requiring an arbitrary duration of failed therapy.
  • Measure the affected region consistently. A normal opposite limb is useful in unilateral disease; bilateral disease needs a different reference and follow-up strategy, not automatic exclusion.
  • Use MRI or other appropriate imaging when needed to distinguish fluid from adipose tissue or plan around prior reconstruction. Bioimpedance measures extracellular fluid; it does not itself measure the amount of fat to remove.
  • Order appropriate postoperative compression in advance and assess whether the patient can apply, tolerate and replace it. Consider assistance, travel, cost and long-term follow-up.

Published centers use different entry criteria: for example, the Australian ALERT cohort required a greater than 20% limb or segment volume difference plus minimal fluid and substantial morbidity. This is a center-specific selection criterion, not a universal 25% threshold. The AVF/AVLS/SVM expert panel itself did not reach consensus on offering reductive surgery after failed conservative care.[3][12]

Operative Principles — Extremity Protocols​

These principles describe specialized limb liposuction. They are not instructions for passing a cannula around the penis, scrotum or spermatic cords.[1][3][11]

  1. Map and protect. Mark the planned treatment region and any previous LVA/VLNT sites. Define the tissue plane and skin viability to preserve. Choose anesthesia, infiltration and tourniquet use for the actual operation.[3][6]
  2. Use controlled longitudinal passes. The ALERT Brorson-based protocol uses multiple small access incisions and power assistance, with cannula movement longitudinal to the limb to reduce lymphatic injury. Circumferential treatment of the limb does not mean circumferentially sweeping the cannula through its lymphatic pathways.[3]
  3. Distinguish dry from tumescent portions. Tourniquet-assisted dry treatment can be followed by tumescent treatment of the proximal region previously under the tourniquet. Both ALERT and the 2026 Sollie technical report describe this combination. Power-assisted liposuction does not inherently prohibit tumescent infiltration, and the available clinical evidence does not establish that infiltration damages lymphatics more than dry treatment.[3][7]
  4. Reassess contour, skin and hemostasis. Use repeat measurements and the patient's anatomy rather than an unconditional aspiration-volume target. A reported reduction beyond 100% is an excess-volume calculation, not an instruction to over-resect.[3]
  5. Provide planned compression and recovery support. In the ALERT tourniquet protocol, compression is applied to the treated segment before tourniquet release, followed by treatment and compression of the proximal segment. This protocol requires trained postoperative care; outpatient or next-day discharge is not a universal standard.[3][7]

No comparative evidence establishes one device, cannula size, infiltration method or combined-treatment sequence as optimal for all patients. The 2026 dry-technique article is a descriptive technical report without a comparative cohort or standardized outcome analysis.[2][7]

Compression and Follow-Up​

Ongoing compression is part of the treatment, not evidence that the operation has cured lymphatic dysfunction. Follow swelling, skin integrity, infection episodes, function and garment fit. Adjust pressure and wearing time with the treating team; new pain, skin breakdown or impaired perfusion requires reassessment.[1][3][6]

The frequently quoted lower-leg pressure around 40 mmHg and thigh pressure around 20 mmHg came from a retrospective study of 19 patients/21 legs, all previously treated with LVA and vascularized lymphatic transfer. Compression groups were small and not randomized. One patient developed a skin ulcer, and the authors explicitly could not establish whether pressure could be reduced after six months following liposuction alone. These findings do not define a universal safe pressure, a genital compression prescription or an automatic six-month taper.[6]

Combined surgery can sometimes reduce compression burden, but cessation should follow documented individual response. A reconstruction does not guarantee permanent freedom from garments.[1][2][5][8]

Interpreting Outcomes​

Excess volume is the difference between affected and comparison limbs. If that excess is fully eliminated, its reduction is 100%; a value above 100% means the treated limb measured smaller than its comparator. It does not mean removal of the entire limb volume. Report the definition, comparator, follow-up denominator and compression protocol alongside percentages.[3][4]

EvidenceFindingLimitation that changes interpretation
Granoff US implementation39 patients, 41 procedures; reported one-year excess-volume reductions of 116% in arms and 115% in legsRetrospective, selected extremity cohort; no genital efficacy estimate or randomized comparison[4]
Karlsson/ALERT five-year report59 included patients: 29 arms and 30 legs; five-year median residual excess volumes 22 mL and 669 mLOnly 12 arm and 6 leg patients had five-year measurements. Changing follow-up populations prevent a simple conclusion that all legs recur or all arms continue improving; five compression-related superficial wounds occurred[3]
Stewart lower-limb series69 patients/72 legs; reported 90% mean excess-volume reduction at five yearsFive-year result was available for 15 legs, compared with 72 at three months; nine years describes the operative experience, not every patient's follow-up[13]
Chen 2025 systematic review52 mostly observational studies of liposuction-based care, predominantly extremitiesMarked heterogeneity, inconsistent reported analytic totals and mixed volume/circumference terminology. Indirect pooled proportions do not establish superiority or a trade-off between standalone and combined surgery[5]

The Chen review narratively summarized compression burden and quality of life; it did not establish a pooled randomized benefit of combination surgery for those endpoints. Its precise percentages should not be presented as a specialist consensus or an expected genital result.[5]

Cellulitis may decrease after successful tissue reduction and continued care, but denominators matter. The often repeated 58% to 15% figure in Granzow's report describes all 26 patients receiving different operations; only ten underwent SAPL. It is not the standalone-SAPL treatment effect.[9]

Combining Liposuction With LVA or VLNT​

The AAPS consensus supports a role for debulking of the non-fluid component and for selected combination treatment, while stating that timing remains unresolved. A sequence may prioritize the dominant component, available collectors, existing reconstruction and the feasibility of postoperative compression.[2]

Brazio's 21-patient retrospective series used different sequences in patients who differed in stage and baseline excess volume. Reported daily garment time decreased from 12.5 to 7.5 hours, but garment class was not reduced and use was self-reported. This supports further evaluation, not a proven universal “3L” algorithm or routine three-procedure operation.[8]

Role in Genital Reconstruction​

Direct evidence for liposuction of genital lymphedema is limited. Advanced penile/scrotal disease often includes abnormal skin, lymphorrhea, dense fibrosis and redundant folds that require tailored excision and coverage. Adjacent suprapubic or thigh bulk and coexisting limb disease should be assessed separately from the genital skin envelope. ISL limb staging or limb volume thresholds do not establish an indication for early genital liposuction.[1][11]

Genital compression can be difficult to fit and maintain, but it is not universally impossible. Determine whether a realistic maintenance plan exists before any operation whose result depends on compression.[11]

Torio-Padron's 51-patient genital series used perioperative CDT and open excision with primary closure, not SAPL. Its three revision-requiring wound complications and quality-of-life improvement cannot be used as liposuction outcomes. Likewise, favorable limb liposuction series do not prove fewer complications, faster recovery or better cosmesis than appropriately selected genital excision.[10]

References​

1. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2023 consensus document of the International Society of Lymphology. Lymphology. 2023;56:133–151. Full consensus

2. Chang DW, Dayan J, Greene AK, et al. Surgical treatment of lymphedema: a systematic review and meta-analysis of controlled trials. Results of a consensus conference. Plast Reconstr Surg. 2021;147(4):975–993. doi:10.1097/PRS.0000000000007783

3. Karlsson T, Mackie H, Koelmeyer L, et al. Liposuction for advanced lymphedema in a multidisciplinary team setting in Australia: 5-year follow-up. Plast Reconstr Surg. 2024;153(2):482–491. doi:10.1097/PRS.0000000000010612

4. Granoff MD, Johnson AR, Shillue K, et al. A single institution multi-disciplinary approach to power-assisted liposuction for the management of lymphedema. Ann Surg. 2022;276(5):e613–e621. doi:10.1097/SLA.0000000000004588

5. Chen J, Feng X, Zhou Y, et al. Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis. Front Oncol. 2025;15:1651472. doi:10.3389/fonc.2025.1651472

6. Yoshida S, Koshima I, Imai H, et al. Effect of postoperative compression therapy on the success of liposuction in patients with advanced lower limb lymphedema. J Clin Med. 2021;10(21):4852. doi:10.3390/jcm10214852

7. Sollie M, Lilja C, Ydo CB, et al. Dry liposuction for upper-extremity end-stage lymphedema: a step-by-step video of technique. Aesthetic Plast Surg. 2026;50:3321–3324. doi:10.1007/s00266-026-05745-y

8. Brazio PS, Nguyen DH. Combined liposuction and physiologic treatment achieves durable limb volume normalization in class II-III lymphedema: a treatment algorithm to optimize outcomes. Ann Plast Surg. 2021;86(5S Suppl 3):S384–S389. doi:10.1097/SAP.0000000000002695

9. Granzow JW, Soderberg JM, Kaji AH, Dauphine C. An effective system of surgical treatment of lymphedema. Ann Surg Oncol. 2014;21(4):1189–1194. doi:10.1245/s10434-014-3515-y

10. Torio-Padron N, Stark GB, Földi E, Simunovic F. Treatment of male genital lymphedema: an integrated concept. J Plast Reconstr Aesthet Surg. 2015;68(2):262–268. doi:10.1016/j.bjps.2014.10.003

11. Vignes S. Genital lymphedema after cancer treatment: a narrative review. Cancers. 2022;14:5809. doi:10.3390/cancers14235809

12. Lurie F, Malgor RD, Carman T, et al. The American Venous Forum, American Vein and Lymphatic Society and the Society for Vascular Medicine expert opinion consensus on lymphedema diagnosis and treatment. Phlebology. 2022;37(4):252–266. doi:10.1177/02683555211053532

13. Stewart CJ, Munnoch DA. Liposuction as an effective treatment for lower extremity lymphoedema: a single surgeon's experience over nine years. J Plast Reconstr Aesthet Surg. 2018;71(2):239–245. doi:10.1016/j.bjps.2017.11.003